And 2 weeks after that (day 29), you’ll start taking 40 mg every other week. Humira is available in a starter kit that helps you follow this dosing schedule. The kit contains prefilled Humira pens.

Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.

but only for the lower concentrations (40 mg/0.8 mL or 20 mg/0.4 mL) of Humira. Most are, however, working to get interchangeable status for their biosimilars, and three of them – Organon ...

Talks between CMS and drugmaker Amgen authorized under the Inflation Reduction Act (IRA), former President Biden's signature ...

Eli Lilly and Company, AbbVie, Merck & Co., Inc., Pfizer, D-Wave Quantum, Johnson & Johnson, and Amgen are the seven ...

Learn more about whether Alvotech or Vericel Corporation is a better investment based on AAII's A+ Investor grades, which ...

Learn more about whether Alvotech or Protagonist Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades ...

Patients with radiographic axial spondyloarthritis who receive ixekizumab biweekly demonstrate lower sacroiliac joint erosion and increased the backfill of new tissue through 52 weeks, according to ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Although that figure isn't much below the maximum price as established in the IRA, which was 40% of the so-called non ... of biosimilars for adalimumab (Humira), a popular alternative for most ...

Today's Research Daily features new research reports on 12 major stocks, including AbbVie Inc. (ABBV), Lockheed Martin ...